Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Post-approval studies (Phase 4)Study completedNCT03361098
What this trial is testing

DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2

Who this might be right for
Type 2 Diabetes MellitusObesity
Amsterdam UMC, location VUmc 65
Not applicableStudy completedNCT00413335
What this trial is testing

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

Who this might be right for
ObesityImpaired Glucose ToleranceType 2 Diabetes Mellitus
Yale University 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660173
What this trial is testing

Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Amgen 409
Not applicableStudy completedNCT06401733
What this trial is testing

Intensive Aerobic and Resistance Exercise Program (IAREP)

Who this might be right for
Type 2 Diabetes MellitusCognitive ImpairmentNon-insulin-dependent Diabetes Mellitus+1 more
National University of Singapore 58
Not applicableStudy completedNCT02667652
What this trial is testing

The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObesity
Weidong Tong 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06987695
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease

Who this might be right for
Obesity Disease
Amgen 279
Large-scale testing (Phase 3)Study completedNCT05405244
What this trial is testing

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

Who this might be right for
Overweight and ObesityEating Behavior
University of North Carolina, Chapel Hill 55
Testing effectiveness (Phase 2)Study completedNCT03444584
What this trial is testing

Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 49
Testing effectiveness (Phase 2)Study completedNCT01918865
What this trial is testing

Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObese
Ionis Pharmaceuticals, Inc. 92
Very early researchEnrolling By InvitationNCT07209527
What this trial is testing

Truway Diagnostic Tools in Primary Care

Who this might be right for
Chronic DiseaseType 2 Diabetes Mellitus (T2DM), Obesity, OverweightHypertension+6 more
Truway Health, Inc. 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06845202
What this trial is testing

Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Who this might be right for
Obese or Overweight Healthy VolunteersType 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals 105
Early research (Phase 1)Study completedNCT00376038
What this trial is testing

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 13
Not applicableUnknownNCT03961659
What this trial is testing

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Who this might be right for
Type 2 Diabetes MellitusObesityCognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Not applicableStudy completedNCT03127696
What this trial is testing

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Who this might be right for
Type2 DiabetesType 2 Diabetes MellitusObese
Chinese University of Hong Kong 61
Not applicableActive Not RecruitingNCT06094491
What this trial is testing

Virtual Diabetes Group Visits Across Health Systems

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)HypertensionHeart Disease Chronic+4 more
University of Chicago 720
Not applicableActive Not RecruitingNCT06735859
What this trial is testing

Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)HypertensionObesity and Type 2 Diabetes+1 more
Federal University of São Paulo 40
Not applicableUnknownNCT03257449
What this trial is testing

Effect of Viscous Soluble Fibres on Body Weight

Who this might be right for
Overweight and ObesityT2DM (Type 2 Diabetes Mellitus)General Population
Unity Health Toronto 1,268
Early research (Phase 1)Study completedNCT06929156
What this trial is testing

BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Overweight or Obese
BrightGene Bio-Medical Technology Co., Ltd. 34
Testing effectiveness (Phase 2)Ended earlyNCT03152552
What this trial is testing

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Who this might be right for
Diabetes Mellitus and Heart Failure
Novartis Pharmaceuticals 125
Next Page